Web Results

Patent Docs: Court Report - Patentdocs.org


Oct 6, 2013 ... Forest Laboratories Inc. et al. v. First Time US Generics LLC 1:13-cv-01642; filed October 2, 2013 in the District Court of Delaware • Plaintiffs: ...

Apotex Exits Forest's Patent Suit Over Generic Savella - Law360


Jan 21, 2016 ... Forest Laboratories Inc. has agreed to drop its claims that Apotex Inc. ... ANDA before the three patents expire without first obtaining a license from Forest. ... Earlier this month, Forest and Amneal Pharmaceuticals LLC entered their ... Apotex Corp. et al., case number 1:13-cv-01602, in the U.S. District Court ....

Sanofi et al v. First Time US Generics LLC - RPX Search


Sanofi et al v. First Time US Generics LLC. 1:14-cv-00293; Filed: 03/06/2014; Closed: 04/14/2016; Latest Docket Entry: 09/23/2016; PACER. Create Alert ...

Doc No. 22 - Court


Nov 6, 2015 ... NOSTRUM PHARMACEUTICALS, LLC, et al.,. Plaintiffs, v. MANISH ... Plaintiffs Nostrum Pharmaceuticals, LLC and Nostrum Laboratories, Inc. subpoenaed ... pharmaceutical business, First Time US Generics, LLC (“FTG”).

Court Report - March 2016 #2 | McDonnell Boehnen Hulbert ...


Mar 14, 2016 ... View the complaint here. Forest Laboratories LLC et al. v. Accord Healthcare Inc. et al. 1:15-cv-00903; filed October 9, 2015 in the District Court ...

Court Report | McDonnell Boehnen Hulbert & Berghoff LLP - JDSupra


Jan 5, 2015 ... Novartis Pharmaceuticals Corp. et al. v. Roxane Laboratories Inc. 1:14-cv-01508; filed... ... part of Roxane's filing of an ANDA to manufacture a generic version of Novartis' Afinitor® (everolimus, used for the ... Forest Laboratories LLC et al. v. ... Plaintiffs: Sanofi-Aventis U.S. LLC; Aventis Pharma S.A.; San...

Judge Sleet | Delaware Intellectual Property Litigation


Nov 12, 2016 ... By Memorandum Opinion entered by The Honorable Gregory M. Sleet in Forest Laboratories, LLC, et al. v. ... its Markman opinion construing seven (7) disputed terms in U.S. Patent Nos. ... Merck & Co., Inc., et al., Civil Action No. ... Defendants , for the first time according to the Court, claimed that the '212 ...

State of New York v. Actavis PLC and Forest Laboratories LLC


Jan 15, 2015 ... A. Regardless of Forest's Proposed Plans, Namenda IR Will. Remain on the Market and Will Face Generic Competition. ................ 4. 1. .... the Pill: Understanding the U.S. Commercial Pharmaceutical Supply. Chain 8 .... Sameer D. Saine, M.D. et al., Effect of Medication Dosing Frequency on. Adherence in ...

State of New York v. Actavis - New York Attorney General


May 28, 2015 ... Plaintiff-Appellee, v. ACTAVIS PLC, FOREST LABORATORIES, LLC, .... This question is an issue of first impression in the circuit courts. Determining ... 631, 658 (2007) (citing Herbert Hovenkamp et al., IP and Antitrust: An Analysis of ... Generic Drugs, http://1.usa.gov/1SjEIso (last visited Apr. 14, 2015).

Memorandum of Law in Support of Motion for a Preliminary Injunction


Oct 30, 2014 ... Defendants' Launch of Namenda and Efforts to Impede Generic ... Forest Makes Conversion of Namenda Patients to Namenda XR the Highest ..... N.Y. Jets LLC v . .... Steve D. Shadowen et al., Anticompetitive Product Changes in the .... Labs. v. Teva Pharms. USA, Inc., 432 F. Supp. 2d 408 (D. Del. 2006).

More Info

Patent Docs: Court Report


Sep 4, 2016 ... Aurobindo Pharma USA Inc. et al. v. ... Plaintiffs: Forest Laboratories, LLC; Forest Laboratories Holdings, Ltd.; Allergan USA, Inc.; Adamas ...

Actavis Says Namenda Product-Hopping Suit Has No Hop - Law360


Dec 23, 2015 ... Forest then agreed to keep the drug on the market until a generic was ... the drugmakers' actions are protected by the First Amendment. ... are Sergeants Benevolent Association Health & Welfare Fund et al. v. ... Forest Laboratories LLC et al., case number 1:15-cv-07488, both in the ... U.S. Supreme Court ....



Sep 24, 2015 ... DC, for amicus curiae Generic Pharmaceutical Associa- tion. ... Roxane Laboratories, Inc., Sandoz Inc. (collectively the ... ants”) appeal the district court's decision in Shire, LLC v. Amneal ... 7,659,253 (the “'253 patent”); and claim 3 of U.S. Patent .... obvious at the time the invention was made to a perso...